Share Name Share Symbol Market Type Share ISIN Share Description
Galapagos Nv LSE:GLPG London Ordinary Share BE0003818359 ORD SHS NO NOMINAL VALUE
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 416.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Unknown - - - - 87.74

Galapagos Share Discussion Threads

Showing 1 to 10 of 25 messages
Chat Pages: 1
DateSubjectAuthorDiscuss
22/4/2013
14:57
Press Releases 2013 April 22, 2013 Galapagos discovers novel candidate drug to treat breast cancer View English version - Bekijk Nederlandse versie
jammytass
04/3/2011
06:46
glpg > has made large profits and will be one of the worlds leading cmpy traded on euronext, wish they would come back to uk market!!!!
jammytass
12/10/2010
05:57
cancer contract> this cmy will be massive
jammytass
04/10/2010
06:39
more good news for this growing group> oh why oh why did they pull from lse
jammytass
20/9/2006
08:56
Mechelen, Belgium; 19 September 2006 - Galapagos NV (Euronext & LSE: GLPG) has placed 1,305,074 new shares in a successful private placement with Fortis Bank NV, at a price of Eur8.50 per share. Fortis intends to place these new shares with international institutional clients via an accelerated bookbuilding procedure. Galapagos raised gross proceeds of Eur11.1 million. The Board of Directors of Galapagos has authorized this capital increase of ยค11.1 million by the issuance of 1,305,074 new ordinary shares, effective as of 19 September 2006, at a price per share of Eur8.50, reflecting the average share price on Euronext Amsterdam over the last 30 days. The new shares are expected to be admitted to trading and listing on Eurolist by Euronext Brussels and Euronext Amsterdam and on AiM on 22 September 2006. As a result of the placement, Galapagos will have 14,355,817 ordinary shares outstanding. http://www.investegate.co.uk/Article.aspx?id=20060920070000H6678
jonwig
06/9/2006
06:50
Collaboration of BioFocus with a US research unit, revenue of $3m over 2.5 years for GLPG. http://www.investegate.co.uk/Article.aspx?id=20060906070000H3611
jonwig
19/7/2006
06:32
Hi gardenboy. I held some of these for about 1 hour last year, when I took part in their T/O of Biofocus; I always meant to look more closely but never got round to it. Since they (ie. the BioFocus division) are involved in partnering other companies' drug discovery efforts, it may be that the partner takes most of the risk, whilst they take the fees - dunno, like you I haven't done the research. Will come back if I find anything to excite me! A chart since admission to AIM:
jonwig
03/4/2006
16:33
no thread so here's one - invested in a few at 670p - as yet I have done no research ! but simply bought some because the share made a new high and now continues to climb - could be interesting
gardenboy
03/4/2006
16:31
Post removed by ADVFN
Abuse team
03/4/2006
16:28
Company website : http://www.glpg.com/
gardenboy
Chat Pages: 1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161205 12:37:42